ArticleCancer management and research2019

Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients.

Yi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.